Elisabeth Nagy

3.2k total citations
84 papers, 2.3k citations indexed

About

Elisabeth Nagy is a scholar working on Clinical Biochemistry, Epidemiology and Infectious Diseases. According to data from OpenAlex, Elisabeth Nagy has authored 84 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Clinical Biochemistry, 36 papers in Epidemiology and 35 papers in Infectious Diseases. Recurrent topics in Elisabeth Nagy's work include Bacterial Identification and Susceptibility Testing (41 papers), Clostridium difficile and Clostridium perfringens research (23 papers) and Streptococcal Infections and Treatments (16 papers). Elisabeth Nagy is often cited by papers focused on Bacterial Identification and Susceptibility Testing (41 papers), Clostridium difficile and Clostridium perfringens research (23 papers) and Streptococcal Infections and Treatments (16 papers). Elisabeth Nagy collaborates with scholars based in Hungary, United Kingdom and Germany. Elisabeth Nagy's co-authors include Edit Urbán, József Sóki, Markus Kostrzewa, Simone Becker, Gabriella Terhes, Ilona Dóczi, Péter Tenke, Gareth Williams, D.J. Stickler and Claus Riedl and has published in prestigious journals such as Nature, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Elisabeth Nagy

81 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elisabeth Nagy Hungary 29 853 798 689 446 390 84 2.3k
E. Nagy Hungary 21 695 0.8× 696 0.9× 725 1.1× 404 0.9× 374 1.0× 52 2.1k
Evgeny A. Idelevich Germany 25 894 1.0× 734 0.9× 592 0.9× 413 0.9× 206 0.5× 82 2.0k
René Courcol France 31 543 0.6× 854 1.1× 976 1.4× 489 1.1× 300 0.8× 116 2.5k
Gilles Quesne France 23 696 0.8× 850 1.1× 1.3k 1.8× 408 0.9× 767 2.0× 33 2.4k
Iris Spiliopoulou Greece 31 696 0.8× 1.3k 1.6× 662 1.0× 930 2.1× 304 0.8× 136 2.7k
Jeong Hwan Shin South Korea 25 404 0.5× 661 0.8× 721 1.0× 483 1.1× 274 0.7× 149 2.0k
Tammy Bannerman United States 17 762 0.9× 1.3k 1.7× 379 0.6× 763 1.7× 306 0.8× 25 2.4k
Gerri S. Hall United States 28 731 0.9× 1.3k 1.7× 1.4k 2.0× 475 1.1× 263 0.7× 91 3.1k
Frida Stock United States 27 512 0.6× 1.0k 1.3× 1.1k 1.5× 602 1.3× 227 0.6× 47 3.0k
Hélène Jean‐Pierre France 31 447 0.5× 479 0.6× 625 0.9× 743 1.7× 281 0.7× 109 2.5k

Countries citing papers authored by Elisabeth Nagy

Since Specialization
Citations

This map shows the geographic impact of Elisabeth Nagy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Nagy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Nagy more than expected).

Fields of papers citing papers by Elisabeth Nagy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Nagy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Nagy. The network helps show where Elisabeth Nagy may publish in the future.

Co-authorship network of co-authors of Elisabeth Nagy

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Nagy. A scholar is included among the top collaborators of Elisabeth Nagy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Nagy. Elisabeth Nagy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Nagy, Elisabeth, et al.. (2023). Fear of making a mistake: a prominent cause of stress for COVID-19 ICU staff—a mixed-methods study. BMJ Open Quality. 12(1). e002009–e002009. 2 indexed citations
3.
Loewenich, Friederike D. von, et al.. (2022). Phenotypic and Molecular Characterization of Carbapenem-Heteroresistant Bacteroides fragilis Strains. Antibiotics. 11(5). 590–590. 9 indexed citations
4.
Jamal, Wafaa, Vincent O. Rotimi, Katalin Burián, et al.. (2021). Molecular characterization of metronidazole resistant Bacteroides strains from Kuwait. Anaerobe. 69. 102357–102357. 5 indexed citations
6.
Toprak, Nurver Ülger, Edit Urbán, Ingrid Wybo, et al.. (2018). Performance of mass spectrometric identification of clinical Prevotella species using the VITEK MS system: A prospective multi-center study. Anaerobe. 54. 205–209. 9 indexed citations
8.
9.
Sóki, József, et al.. (2012). Molecular analysis of the carbapenem and metronidazole resistance mechanisms of Bacteroides strains reported in a Europe-wide antibiotic resistance survey. International Journal of Antimicrobial Agents. 41(2). 122–125. 47 indexed citations
10.
Sóki, József, et al.. (2011). Investigation of the prevalence of tetQ, tetX and tetX1 genes in Bacteroides strains with elevated tigecycline minimum inhibitory concentrations. International Journal of Antimicrobial Agents. 38(6). 522–525. 68 indexed citations
11.
Alba, Verònica, Edit Urbán, M.Á. Domínguez, et al.. (2008). In vitro activity of nadifloxacin against several Gram-positive bacteria and analysis of the possible evolution of resistance after 2 years of use in Germany. International Journal of Antimicrobial Agents. 33(3). 272–275. 20 indexed citations
12.
Nagy, Elisabeth, I. Szöke, László Török, & László Pajor. (2005). The Role of Anaerobic Bacteria in Prostatitis. Kluwer Academic Publishers eBooks. 485. 289–299. 3 indexed citations
13.
Sóki, József, Micaela Gal, John Brazier, et al.. (2005). Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. Journal of Antimicrobial Chemotherapy. 57(2). 212–220. 60 indexed citations
14.
Tenke, Péter, et al.. (2004). Bacterial biofilm formation on urologic devices and heparin coating as preventive strategy. International Journal of Antimicrobial Agents. 23. 67–74. 123 indexed citations
15.
Sóki, József, et al.. (2004). Screening of isolates from faeces for carbapenem-resistant Bacteroides strains; existence of strains with novel types of resistance mechanisms. International Journal of Antimicrobial Agents. 24(5). 450–454. 17 indexed citations
16.
Kredics, László, Zsuzsanna Antal, András Szekeres, et al.. (2004). Production of Extracellular Proteases by Human PathogenicTrichoderma longibrachiatumStrains. Acta Microbiologica et Immunologica Hungarica. 51(3). 283–295. 18 indexed citations
17.
Kredics, László, Zsuzsanna Antal, Ilona Dóczi, et al.. (2003). Clinical importance of the genusTrichoderma. Acta Microbiologica et Immunologica Hungarica. 50(2-3). 105–117. 79 indexed citations
18.
Deák, J, et al.. (1997). Prevalence of Chlamydia trachomatis Infection in a Low-Risk Population in Hungary. Sexually Transmitted Diseases. 24(9). 538–542. 7 indexed citations
19.
Nagy, Elisabeth, et al.. (1991). Inactivatin of metronidazole by Enterococcus faecalis. Journal of Antimicrobial Chemotherapy. 27(1). 63–70. 46 indexed citations
20.
Nagy, Elisabeth, et al.. (1991). Antibiosis between bacteria isolated from the vagina of women with and without signs of bacterial vaginosis. Apmis. 99(7-12). 739–744. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026